Anixa Biosciences ANIX
NASDAQ ANIX
$2.77 -0.16 (-5.46%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anixa Biosciences (ANIX) Gross Profit (2010 - 2012)

Updated

Anixa Biosciences (ANIX) reported Gross Profit of -$1,575 for fiscal Q4 2012 (quarter ended Oct 31, 2012), compared with $448,363 a year earlier.

Analysis

Anixa Biosciences (ANIX) Gross Profit (2010 - 2012) Analysis & Trends

For FY2012 (ended Oct 31, 2012), Anixa Biosciences posted Gross Profit of $943,212, down 2.7% from FY2011.

  • By fiscal year, Gross Profit came in at $969,112 in FY2011 (+49.5%) and $648,368 in FY2010.
  • The fiscal Q4 2012 figure ranks as the lowest quarterly Gross Profit in data going back to fiscal Q3 2010.
  • Per Business Quant data, the three fiscal quarters before Q4 2012 came in at $248,756 (Q3 2012), $247,573 (Q2 2012) and $448,458 (Q1 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Anixa Biosciences 101.33 Mn 100.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -1,575.00
Jul 31, 2012 248,756.00
Apr 30, 2012 247,573.00
Jan 31, 2012 448,458.00
Oct 31, 2011 448,363.00
Jul 31, 2011 446,734.00
Apr 30, 2011 62,263.00
Jan 31, 2011 11,752.00
Oct 31, 2010 303,998.00
Jul 31, 2010 24,026.00
API Access

Anixa Biosciences Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=ANIX&period=max&api_key=YOUR_API_KEY